Published in Lakartidningen on March 21, 2007
[Stent treatment of carotid stenosis does have a future!]. Lakartidningen (2007) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature (2016) 2.53
[Screening for abdominal aortic aneurysm saves lives at a reasonable cost]. Lakartidningen (2003) 1.96
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol (2006) 1.95
Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet (2010) 1.86
Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol (2005) 1.85
Prevention of venous thromboembolism. Chest (2005) 1.76
Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg (2005) 1.72
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation (2008) 1.64
Haemostatic markers in patients with abdominal aortic aneurysm and the impact of aneurysm size. Thromb Res (2009) 1.51
Iatrogenic vascular injuries in varicose vein surgery: a systematic review. World J Surg (2007) 1.49
Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg (2003) 1.48
Long-term survival after carotid endarterectomy for asymptomatic stenosis. Stroke (2006) 1.41
[Diagnosis of acute pulmonary embolism. Simplified strategy based on clinical probability, D-dimer and computer tomography]. Lakartidningen (2006) 1.40
[Electromagnetic therapy of circulatory disorders in the lower extremities. Promising advertisements in daily press are not scientifically documented]. Lakartidningen (2005) 1.38
[A promising start for quality indicator work within vascular surgery?]. Lakartidningen (2002) 1.38
A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg (2007) 1.33
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest (2014) 1.29
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A (2006) 1.28
Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cells. J Biol Chem (2002) 1.26
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2004) 1.21
Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J (2005) 1.19
Increasing incidence of ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg (2006) 1.18
Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost (2007) 1.16
Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res (2008) 1.15
Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg (2005) 1.15
Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg (2009) 1.12
Trousseau's syndrome - what is the evidence? A population-based autopsy study. Thromb Haemost (2006) 1.09
[In Process Citation]. Lakartidningen (2015) 1.07
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol (2008) 1.06
Hemodynamics of the normal aorta compared to fusiform and saccular abdominal aortic aneurysms with emphasis on a potential thrombus formation mechanism. Ann Biomed Eng (2010) 1.06
The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst (2009) 1.06
Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res (2004) 1.05
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. Circulation (2012) 0.99
Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 0.99
Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg (2005) 0.99
Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.98
Cost-effectiveness of screening women for abdominal aortic aneurysm. J Vasc Surg (2006) 0.98
Noninvasive real-time imaging of intima thickness after rat carotid artery balloon injury using ultrasound biomicroscopy. Atherosclerosis (2008) 0.97
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet (2002) 0.97
State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis. Clin Appl Thromb Hemost (2009) 0.97
High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients. J Nucl Med (2008) 0.97
Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta. J Am Coll Cardiol (2007) 0.96
Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry. J Vasc Surg (2006) 0.96
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis (2011) 0.95
Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol (2005) 0.94
Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg (2002) 0.93
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis. Atherosclerosis (2012) 0.92
Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation (2002) 0.90
Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res (2005) 0.90
Fatal colonic ischemia: A population-based study. Scand J Gastroenterol (2006) 0.90
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88
Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease. Eur J Cardiovasc Prev Rehabil (2009) 0.87
Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy. Mol Med (2012) 0.87
Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation (2004) 0.86
Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg (2007) 0.86
Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture. Exp Cell Res (2002) 0.86
Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients. Ann Surg (2005) 0.86
The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. Atherosclerosis (2011) 0.85
Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. J Vasc Surg (2010) 0.85
Current options in the prevention of thromboembolic disease. Drugs (2004) 0.85
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling. J Vasc Surg (2007) 0.84
Proinflammatory and anti-inflammatory cytokine balance in patients with abdominal aortic aneurysm and the impact of aneurysm size. Vasc Endovascular Surg (2009) 0.84
Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol (2012) 0.84
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion. J Mol Med (Berl) (2010) 0.84
NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.84
Low quality of life prior to screening for abdominal aortic aneurysm: a possible risk factor for negative mental effects. Ann Vasc Surg (2004) 0.84
The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. J Vasc Surg (2009) 0.84
Identification of endothelial proteins by MALDI-MS using a compact disc microfluidic system. Protein J (2004) 0.83
Changes in superficial and perforating vein reflux after varicose vein surgery. J Vasc Surg (2005) 0.83
Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur J Immunol (2014) 0.82
The Hardman index in patients operated on for ruptured abdominal aortic aneurysm: A systematic review. J Vasc Surg (2006) 0.82
Activation of fibrinolysis and coagulation in non-occlusive intestinal ischaemia in a pig model. Blood Coagul Fibrinolysis (2004) 0.82
Low frequency of phlebographic deep vein thrombosis after laparoscopic cholecystectomy--a pilot study. Clin Appl Thromb Hemost (2006) 0.82
Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. J Cell Physiol (2002) 0.81
Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury. J Vasc Res (2015) 0.81
Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation. Am J Physiol Heart Circ Physiol (2007) 0.80
Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins. Mol Cell Biochem (2003) 0.80
Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study. J Vasc Interv Radiol (2005) 0.80
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization. Atherosclerosis (2012) 0.79
Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction. Arterioscler Thromb Vasc Biol (2008) 0.79
Differences in presentation of symptoms between women and men with intermittent claudication. BMC Cardiovasc Disord (2011) 0.79
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis (2006) 0.78
Education in vascular surgery: critical issues around the globe-training and qualification in vascular surgery in Europe. J Vasc Surg (2008) 0.78
[Recommendations by the Swedish Quality Board for Carotid Surgery. Ultrasound good preoperative method for evaluating degree of carotid stenosis]. Lakartidningen (2003) 0.78
Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery. Eur J Health Econ (2007) 0.78
Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgery. Curr Opin Pulm Med (2002) 0.78
Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden. Eur J Health Econ (2003) 0.78
Early inflammatory response in patients with ruptured abdominal aortic aneurysm. Vasc Endovascular Surg (2009) 0.78
Arterial stiffness is not improved in long-term use of estrogen. Am J Obstet Gynecol (2002) 0.77
The effects of carbon dioxide versus ioxaglate in the rat kidney. J Vasc Interv Radiol (2005) 0.76
Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis (2002) 0.76
Identification of carotid plaque tissue properties using an experimental-numerical approach. J Mech Behav Biomed Mater (2013) 0.76
Platelet adhesion on endothelium early after vein grafting mediates leukocyte recruitment and intimal hyperplasia in a murine model. Thromb Haemost (2014) 0.76
Anticoagulation and neuraxial regional anesthesia: perspectives. Reg Anesth Pain Med (2003) 0.76
Regarding "Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease". J Vasc Surg (2007) 0.75